Bridget E. Bunner

Array ( [id] => 142100 [patent_doc_number] => 07687513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-03-30 [patent_title] => 'Aminopyridinium ionic liquids' [patent_app_type] => utility [patent_app_number] => 11/254782 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 33 [patent_no_of_words] => 21422 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687513.pdf [firstpage_image] =>[orig_patent_app_number] => 11254782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441824 [patent_doc_number] => 20090093463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'NOVEL COMPOUNDS OF SUBSTITUTED AND UNSUBTITUTED ADAMANTYL AMIDES' [patent_app_type] => utility [patent_app_number] => 11/718327 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19271 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093463.pdf [firstpage_image] =>[orig_patent_app_number] => 11718327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534136 [patent_doc_number] => 20090233924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => utility [patent_app_number] => 11/665125 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74449 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233924.pdf [firstpage_image] =>[orig_patent_app_number] => 11665125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853190 [patent_doc_number] => 20080318933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => '5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders' [patent_app_type] => utility [patent_app_number] => 11/576070 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22508 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318933.pdf [firstpage_image] =>[orig_patent_app_number] => 11576070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103228 [patent_doc_number] => 07723519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Hybrid 2-aminoterailin and aryl-substituted piperazine compounds and their use in altering CNS activity' [patent_app_type] => utility [patent_app_number] => 11/235612 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723519.pdf [firstpage_image] =>[orig_patent_app_number] => 11235612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338024 [patent_doc_number] => 20090054488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Isomigrastatin Analogs In The Treatment Of Cancer' [patent_app_type] => utility [patent_app_number] => 11/663580 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 39357 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054488.pdf [firstpage_image] =>[orig_patent_app_number] => 11663580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7593136 [patent_doc_number] => 07652065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-26 [patent_title] => 'Tellurium compounds and their use as immunomodulators' [patent_app_type] => utility [patent_app_number] => 11/663031 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 13253 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/652/07652065.pdf [firstpage_image] =>[orig_patent_app_number] => 11663031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582715 [patent_doc_number] => 07456567 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Organic electroluminescent device, and azepine compound and method for producing the same' [patent_app_type] => utility [patent_app_number] => 11/223038 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8665 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456567.pdf [firstpage_image] =>[orig_patent_app_number] => 11223038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4548744 [patent_doc_number] => 07960402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Carbamoyl-substituted spiro derivative' [patent_app_type] => utility [patent_app_number] => 11/662102 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44763 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960402.pdf [firstpage_image] =>[orig_patent_app_number] => 11662102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221065 [patent_doc_number] => 07608611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Hsp90 inhibitors, methods of making and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/218320 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 11422 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608611.pdf [firstpage_image] =>[orig_patent_app_number] => 11218320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853036 [patent_doc_number] => 07378420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Urea derivatives as calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 11/215064 [patent_app_country] => US [patent_app_date] => 2005-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15276 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378420.pdf [firstpage_image] =>[orig_patent_app_number] => 11215064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4524274 [patent_doc_number] => 07951816 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Compound containing basic group and use thereof' [patent_app_type] => utility [patent_app_number] => 11/661270 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70389 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951816.pdf [firstpage_image] =>[orig_patent_app_number] => 11661270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265576 [patent_doc_number] => 20090118261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'QUINAZOLINONE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/574031 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35346 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118261.pdf [firstpage_image] =>[orig_patent_app_number] => 11574031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716142 [patent_doc_number] => 20060079505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 11/208386 [patent_app_country] => US [patent_app_date] => 2005-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34036 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079505.pdf [firstpage_image] =>[orig_patent_app_number] => 11208386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609330 [patent_doc_number] => 20060270846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Amphiphilic molecular modules and constructs based thereon' [patent_app_type] => utility [patent_app_number] => 11/207383 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20943 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270846.pdf [firstpage_image] =>[orig_patent_app_number] => 11207383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550705 [patent_doc_number] => 08063038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Heterocyclic condensed compounds useful as antidiuretic agents' [patent_app_type] => utility [patent_app_number] => 11/660207 [patent_app_country] => US [patent_app_date] => 2005-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17155 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063038.pdf [firstpage_image] =>[orig_patent_app_number] => 11660207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851833 [patent_doc_number] => 20060235024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/060470 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22908 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235024.pdf [firstpage_image] =>[orig_patent_app_number] => 11060470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913618 [patent_doc_number] => 20060128680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Macrocyclic module compositions' [patent_app_type] => utility [patent_app_number] => 11/199913 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20084 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128680.pdf [firstpage_image] =>[orig_patent_app_number] => 11199913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704 [patent_doc_number] => 07812041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Heterocyclic NF-κB inhibitors' [patent_app_type] => utility [patent_app_number] => 11/192009 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22222 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812041.pdf [firstpage_image] =>[orig_patent_app_number] => 11192009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11522720 [patent_doc_number] => 09606114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Multivalent chelators containing a scaffold structure for modifying and organizing of target molecules' [patent_app_type] => utility [patent_app_number] => 11/573253 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 26 [patent_no_of_words] => 10278 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11573253 [rel_patent_id] =>[rel_patent_doc_number] =>)